Bisoprolol Fumarate

Images are for illustration purposes only;
actual packaging may vary.

Bisoprolol Fumarate is a selective beta-1 adrenergic receptor blocker commonly used in the management of cardiovascular conditions such as hypertension and heart failure. By selectively targeting beta-1 receptors, it effectively reduces heart rate and cardiac output, leading to decreased blood pressure and improved cardiac function.

This API is favored for its cardioselectivity, which minimizes the risk of bronchoconstriction and other side effects associated with non-selective beta blockers. Its pharmacokinetic profile allows for once-daily dosing, enhancing patient compliance and therapeutic outcomes. Bisoprolol Fumarate is often utilized in personalized compounded formulations to meet specific patient needs, ensuring optimal therapeutic efficacy and safety.

Trusted by 60,357 patients to date.

A group of faces of our past satisfied patients.

Custom made in our compounding labs.

Personalized treatment for better results.

All strengths and ingredients are tailored to your needs.

This medication is not available at retail pharmacies. It is compounded, and may be more effective at treating you or your patient.

This is some text inside of a div block.

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5

Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

Item 1
Item 2
Item 3

Unordered list

Item A
Item B
Item C

Text link

Bold text

Emphasis

^Superscript

_Subscript

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Active Ingredient Information

Bisoprolol Fumarate is a selective beta-1 adrenergic receptor blocker commonly used in the management of cardiovascular conditions such as hypertension and chronic heart failure. By selectively targeting beta-1 receptors, Bisoprolol Fumarate effectively reduces heart rate and cardiac output, leading to decreased blood pressure and improved cardiac efficiency.

This API is particularly beneficial for patients who require precise control over their cardiovascular function, as it minimizes the risk of bronchoconstriction and other side effects associated with non-selective beta blockers. Its pharmacokinetic profile allows for once-daily dosing, enhancing patient compliance and therapeutic outcomes.

In clinical practice, Bisoprolol Fumarate is often chosen for its favorable safety profile and its ability to be tailored in compounded formulations to meet specific patient needs. It is metabolized primarily by the liver and excreted by the kidneys, making it important for prescribers to consider renal and hepatic function when determining appropriate dosing regimens.

Furthermore, Bisoprolol Fumarate has been shown to improve survival rates in patients with heart failure, making it a critical component in the management of this condition. Its use in combination with other antihypertensive agents can provide synergistic effects, offering comprehensive cardiovascular protection.

Formulas using

Bisoprolol Fumarate

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.